参考文献/References:
\[1\] 刘 梦.环境污染对肿瘤发病率的动态效应分析\[D\].武汉:华中科技大学,2015.
\[2\] 吴 菲,林国桢,张晋昕.我国恶性肿瘤发病现状及趋势\[J\].中国肿瘤,2012,21(2):8185.
\[3\] 吴琦玮,沈 榕,张 莉.超声微探头辅助内镜对食管癌早期筛查及癌前病变诊断价值分析\[J\].陕西医学杂志,2018,47(7):886888.
\[4\] 王 俊,王丽丹,江启成.我国肿瘤患者生命质量评价研究现状及特点\[J\].中华疾病控制杂志,2017,21(4):422424.
\[5\] Kobayashi M,Kato K,Iwama H,et al. Antitumor effect of metformin in esophageal cancer:in vitro study\[J\].Int J Oncol,2013,42(2):517524.
\[6\] 李国仁,于世忠.中国继发性食管癌的现状和进展\[J\].中华胸部外科电子杂志,2018,5(1):5358.
\[7\] Garber AJ,Duncan TG,Goodman AM,et al.Efficacy of metformin in type II diabetes:results of a doubleblind ,placebocontrolled ,doseresponse trieal\[J\].Am J Med,1997,103:491497.
\[8\] DeFronzo RA,Goodman AM.Efficacy of metformin in patients with noninsulindependent diabetes mellitus:The Multicenter Metformin Study Group\[J\].N Engl Med,1995,333:541549.
\[9\] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)\[J\].中国糖尿病杂志,2014,22(2):附录.〖ZK)〗
\[10\] Ji L,Han P,Wang X,et al.A randomized clinical trial of the safe and efficacy of sitagliptin and metformin coadministered to Chinese patients with type 2 diabetes mellitus\[J\].J Diabetes Investig,2016,19:727736.
\[11\] Ji L,Li H,Guo X ,et al.Impact of beseline BMI on glycemin control and weight change with metformin monotherapy inchinese type 2 diabetes patients.phase IV openlabel trial\[J\]. PLoS One ,2013,8:e57222.
\[12\] Evans JM ,Donnelly LA ,EmslieSmith AM ,et al. Metformin and reduced risk of cancer in diabetic patients\[J\].Br Med J,2005,330:13041305.
\[13\] 母义明,纪立农,宁 光,等.二甲双胍临床应用专家共识(2016年版)\[J\].中国糖尿病杂志,2016,24(10):871884.〖ZK)〗
\[14\] 姜 宁,路 平.二甲双胍抗肿瘤作用机制\[J\].新乡医学院学报,2016,33(2): 150152.
\[15\] Evans JM,Donnelly LA,Emsliesmith AM,et al.Metformin and reduced risk of cancer in diabetic patients\[J\]. BMJ, 2005,330( 7503) : 13041305.
\[16\] Bowker SL,Majumdars R,Veugelers P,et al.Increased cancerrelated mortality for patients with type 2 diabetes who use sulfonylureas or insulin[J].Diabetes Care,2006,29( 2):254258.
\[17\] Radenkovic S,Konjevic G,Jurisic V,et al. Values of MMP2 and MMP9 in tumor tissue of basallike breast cancer patients\[J\].Cell Biochem Biophysics,2014, 68(1):143152.
\[18\] Lu W,Xia YH,Qu JJ, et al. p21activated kinase 4 regulation of endometrial cancer cell migration and invasion involves the ERK1 /2 pathway mediated MMP2 secretion\[J\]. Neoplasma,2013,60( 5) : 493503.
\[19\] Chen YJ,Lee LY,Chao Y K,et al. DSG3 facilitates cancer cell growth and invasion through the DSG3plakoglobinTCF/LEFMyc /Cyclin D1 /MMP signaling pathway\[J\]. PLoS One,2013,8( 5) : e64088.
\[20\] Chen F,Bai J,Li W,et al. RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma \[J\].PLoS One,2013,8(2):e56241.
\[21\] Yanal,Seikim.MTMMPs play pivotal roles in cancer dissemination\[J\]. Clin ExP Metastasis,2002,19(3):209225.
\[22\] Liao H,Wang ZQ ,Deng ZP, et al.Curcumin inhibits lung cancer invasion and metastasis by attenuating GLUT1/MT1MMP/MMP2 pathway\[J\].International Journal of Clinical and Experimental Medicine,2015,6(8):894857.